文献速递膀胱癌与上尿路尿路上皮癌

饮食与运动与膀胱癌患者的骨骼肌质量及肌少症无关

Diet and Exercise Are not Associated with Skeletal Muscle Mass and Sarcopenia in Patients with Bladder Cancer.
PubMed 文献 · Eur Urol Oncol · 2019-05-25

研究纳入1996年1月1日至2017年6月30日在杜克大学医学中心接受过治疗的285例组织学确诊膀胱癌患者,评估饮食(DHQ-II)、运动(IPAQ-L)与CT L3层面骨骼肌指数(SMI)的关系。多因素线性回归显示总运动量、运动强度、各营养组分及HEI2010饮食质量均与SMI无关,肌少症可能主要受不可改变因素影响。

要点

  • 285例膀胱癌生存者中,符合肌少症定义的比例男性为72%、女性为55%。
  • 多因素分析示总运动量(p=0.830)、运动强度(p=0.874)与SMI无关。
  • 每日热量(p=0.739)、脂肪(p=0.259)、碳水化合物(p=0.983)、蛋白质(p=0.341)及HEI2010饮食质量(p=0.822)与SMI无关。

核心结论

  • 饮食质量与运动等生活方式因素与SMI无关,因此对肌少症的影响似乎有限。
  • 肌少症可能主要受不可改变的危险因素影响。

研究设计与样本

  • 研究纳入1996年1月1日至2017年6月30日在杜克大学医学中心有诊疗史的18岁以上、组织学确诊膀胱癌患者。
  • 采用DHQ-II评估饮食摄入模式,采用IPAQ-L评估体力活动,并由DHQ-II结果计算HEI2010评分。
  • 采用Slice-O-Matic对CT图像L3层面进行分析评估身体成分,由三名独立评估者计算骨骼肌指数(SMI)。

主要发现

  • 共285例患者纳入评估,评估者间平滑肌面积的组内相关系数为0.97(95%CI:0.94-0.98)。
  • 符合肌少症定义的患者比例男性为72%、女性为55%。
  • 单因素线性回归显示年龄较大、男性、黑人种族是SMI的高度显著预测因素,而肿瘤分期与分级、化疗及手术操作不是SMI的预测因素。
  • 多因素线性回归显示总运动量(p=0.830)、运动强度(高、中、低)(p=0.874)、每日热量(p=0.739)、脂肪(p=0.259)、碳水化合物(p=0.983)、蛋白质(p=0.341)及HEI2010饮食质量(p=0.822)均与SMI无关。

临床怎么用

  • 原文结论未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is limited understanding about why sarcopenia is happening in bladder cancer, and which modifiable and nonmodifiable patient-level factors affect its occurrence. OBJECTIVE: The objective is to determine the extent to which nonmodifiable risk factors, modifiable lifestyle risk factors, or cancer-related factors are determining body composition changes and sarcopenia in bladder cancer survivors. DESIGN, SETTING, AND PARTICIPANTS: Patients above 18 yr of age with a histologically confirmed diagnosis of bladder cancer and a history of receiving care at Duke University Medical Center between January 1, 1996 and June 30, 2017 were included in this study. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Bladder cancer survivors from our institution were assessed for their dietary intake patterns utilizing the Diet History Questionnaire II (DHQ-II) and physical activity utilizing the International Physical Activity Questionnaire long form (IPAQ-L) tools. Healthy Eating Index 2010 (HEI2010) scores were calculated from DHQ-II results. Body composition was evaluated using Slice-O-Matic computed tomography scan image analysis at L3 level and the skeletal muscle index (SMI) calculated by three independent raters. RESULTS AND LIMITATIONS: A total of 285 patients were evaluated in the study, and the intraclass correlation for smooth muscle area was 0.97 (95% confidence interval: 0.94-0.98) between raters. The proportions of patients who met the definition of sarcopenia were 72% for men and 55% of women. Univariate linear regression analysis demonstrated that older age, male gender, and black race were highly significant predictors of SMI, whereas tumor stage and grade, chemotherapy, and surgical procedures were not predictors of SMI. Multivariate linear regression analysis demonstrated that modifiable lifestyle factors, including total physical activity (p=0.830), strenuousness (high, moderate, and low) of physical activity (p=0.874), individual nutritional components (daily calories, p=0.739; fat, p=0.259; carbohydrates, p=0.983; and protein, p=0.341), and HEI2010 diet quality (p=0.822) were not associated with SMI. CONCLUSIONS: Lifestyle factors including diet quality and physical activity are not associated with SMI and therefore appear to have limited impact on sarcopenia. Sarcopenia may largely be affected by nonmodifiable risk factors. PATIENT SUMMARY: In this report, we aim to determine whether lifestyle factors such as diet and physical activity were the primary drivers of body composition changes and sarcopenia in bladder cancer survivors. We found that lifestyle factors including dietary habits, individual nutritional components, and physical activity do not demonstrate an association with skeletal muscle mass, and therefore may have limited impact on sarcopenia.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Wang Y, Chang A, Tan WP, et al. Diet and Exercise Are not Associated with Skeletal Muscle Mass and Sarcopenia in Patients with Bladder Cancer. Eur Urol Oncol. 2019. PMID: 31133436. doi:10.1016/j.euo.2019.04.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。